Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
O'Reilly
R J
RJ
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Lacerda
J F
JF
Lucas
K G
KG
Rosenfield
N S
NS
Small
T N
TN
Papadopoulos
E B
EB
D001402:B-Lymphocytes / Q000276:immunology / Q000821:virology; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002472:Cell Transformation, Viral; D002986:Clinical Trials as Topic; D006566:Herpesviridae Infections / Q000628:therapy*; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D016867:Immunocompromised Host; D016219:Immunotherapy, Adoptive; D016393:Lymphoma, B-Cell / Q000209:etiology / Q000628:therapy*; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000276:immunology / Q000628:therapy / Q000821:virology; D012074:Remission Induction; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000637:transplantation*; D014019:Tissue Donors; D014180:Transplantation / Q000009:adverse effects; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014412:Tumor Virus Infections / Q000628:therapy*